SEC Filing Analysis: CORCEPT THERAPEUTICS INC (CORT)

Executive Summary

• Trading Significance: Low
• Key Takeaway: An officer conducted a routine, pre-planned 'exercise and sell' transaction under a 10b5-1 plan, resulting in no net change to their common stock holdings.
• Market Impact: Negligible. The transaction represents a tiny fraction of the company's market capitalization and was pre-scheduled, indicating it is not based on new non-public information.

Company Information

Field	Value
Company	CORCEPT THERAPEUTICS INC
Ticker Symbol	CORT
CIK	0001088856
Industry	PHARMACEUTICAL PREPARATIONS

Insider Information

Field	Value
Name	Lyon Joseph Douglas
CIK	0001817838
Title/Position	Chief Accounting & Technology Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-11-03
Transaction Code	S (Sale)
Security Type	Common Stock
Shares Involved	5,000
Price Per Share	$73.6489
Total Value	$368,244.50
Shares Owned After	10,277
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$368,244.50
% of Market Cap	0.005%
Shares Transacted	5,000
% of Shares Outstanding	0.005%
Post-Transaction Ownership	10,277 shares (0.01% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The $368k sale is insignificant against Corcept's market capitalization of $7.74 billion.
• Ownership Concentration: The insider's post-transaction ownership of 10,277 shares is a very small fraction of the 105.4 million shares outstanding.
• Transaction Significance: This transaction is a classic 'cashless exercise' where an insider exercises stock options (acquiring 5,000 shares at $13.56) and immediately sells the same number of shares to cover the exercise cost and realize a profit. The net change in common stock ownership is zero.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The sale was executed under a pre-arranged 10b5-1 trading plan, which reduces its significance as a market signal. The size of the transaction is immaterial relative to the company's market cap and daily trading volume.

Volume & Sentiment

• Expected Volume Impact: Minimal. The transaction size is unlikely to have a noticeable effect on trading volume.
• Sentiment Indicator: Neutral. Pre-planned sales for diversification or to cover option exercises are common and typically do not influence market sentiment.

Additional Context

Special Circumstances

• 10b5-1 Plan: The filing explicitly states the sale was made pursuant to a 10b5-1 plan adopted on August 30, 2024. This indicates the sale was pre-scheduled and not a reaction to recent events.